35
Back to basics! Substance abuse/drug addiction/withdrawal March 19, 2012 Dr. Gabrielle Cyr PGY-3 resident, psychiatry University of Ottawa

Back to basics! Substance abuse/drug addiction/withdrawal March 19, 2012 Dr. Gabrielle Cyr PGY-3 resident, psychiatry University of Ottawa

Embed Size (px)

Citation preview

Page 1: Back to basics! Substance abuse/drug addiction/withdrawal March 19, 2012 Dr. Gabrielle Cyr PGY-3 resident, psychiatry University of Ottawa

Back to basics!Substance abuse/drug addiction/withdrawal

March 19, 2012Dr. Gabrielle Cyr

PGY-3 resident, psychiatryUniversity of Ottawa

Page 2: Back to basics! Substance abuse/drug addiction/withdrawal March 19, 2012 Dr. Gabrielle Cyr PGY-3 resident, psychiatry University of Ottawa

Objectives

• Key objectives– Determine whether the patient is in need of

emergency care because of withdrawal symptoms or other complications

• Objectives– Take an efficient/focused addictions history– List/interpret clinical/laboratory findings which are

key to the processes of exclusion/differentiation and diagnosis

– Conduct and effective initial plan of management for a patient with substance abuse

Page 3: Back to basics! Substance abuse/drug addiction/withdrawal March 19, 2012 Dr. Gabrielle Cyr PGY-3 resident, psychiatry University of Ottawa

Why do we care?

• Anybody can be affected (++ common)

• All specialties of medicine

• Major psychosocial/functionnal impacts

• Potentially lethal

Page 4: Back to basics! Substance abuse/drug addiction/withdrawal March 19, 2012 Dr. Gabrielle Cyr PGY-3 resident, psychiatry University of Ottawa

Basics of addiction

• Genetic vulnerability

• Environmental factors– Low socioeconomic status– Chaotic background– Etc…

• Repeated use

Page 5: Back to basics! Substance abuse/drug addiction/withdrawal March 19, 2012 Dr. Gabrielle Cyr PGY-3 resident, psychiatry University of Ottawa

Creating an addiction

• Drugs→ activation of the reward system of the brain (mesolimbic dopamine system)→flooding of Dopamine

• Repeated use = changes in function

• ↓Dopamine/Dopa receptor production→ need ↑amounts of drugs to create pleasure

Page 6: Back to basics! Substance abuse/drug addiction/withdrawal March 19, 2012 Dr. Gabrielle Cyr PGY-3 resident, psychiatry University of Ottawa

Substances

• Depressants– Alcohol– Benzodiazepines– Barbiturates– Opioids

• Stimulants– Amphetamines– Cocaine– Cannabis– Hallucinogens (MDMA, LSD, Psilocybin, Mescaline)

Page 7: Back to basics! Substance abuse/drug addiction/withdrawal March 19, 2012 Dr. Gabrielle Cyr PGY-3 resident, psychiatry University of Ottawa

Taking a substance history

• Recent (last 6 months-1 year)/past pattern of abuse– Type of substance/route of administration– Quantity/frequency of use/schedule– Severity of use (abuse vs dependence)

• Impacts of use– Social/occupationnal/legal (DUI, probation, CAS

involvement, etc.)– Medical complications (IV DU, etc.)

Page 8: Back to basics! Substance abuse/drug addiction/withdrawal March 19, 2012 Dr. Gabrielle Cyr PGY-3 resident, psychiatry University of Ottawa

Taking a substance history

• Family history of substance use

• Current/past withdrawal symptoms, severe withdrawal reactions (DT’s, withdrawal seizures, etc.)

• Past treatments for addictions

• Support system

Page 9: Back to basics! Substance abuse/drug addiction/withdrawal March 19, 2012 Dr. Gabrielle Cyr PGY-3 resident, psychiatry University of Ottawa

Physical examination

• Cognition/LOC/Orientation

• Signs of intoxication (toxidromes)/withdrawal– Vitals– Skin (signs of liver failure, needle marks, etc.)– Pupils– Etc.

• +/- complete physical exam

Page 10: Back to basics! Substance abuse/drug addiction/withdrawal March 19, 2012 Dr. Gabrielle Cyr PGY-3 resident, psychiatry University of Ottawa

DSM-IV criteria: abuse

A. Maladaptive pattern of substance use leading to clinically significant impairment or distress, as manifested by one (or more) of the following occurring within a 12 month period:1. recurrent substance use resulting in a failure to fulfill major obligations at work, school, or home2. recurrent substance use in situations in which it is physically hazardous3. recurrent substance-related legal problems4. continued use despite persistent or recurrent social or interpersonal problems caused by or exacerbated by effects of a substance

B. The symptoms have never met the criteria for substance dependence for this class of substance

Page 11: Back to basics! Substance abuse/drug addiction/withdrawal March 19, 2012 Dr. Gabrielle Cyr PGY-3 resident, psychiatry University of Ottawa

DSM-IV criteria: dependence

• 3 or more occurring over 12 months:– tolerance– withdrawal– larger amounts or longer period of time– unsuccessful efforts to cut down or control– time spent obtaining, using, recovering– activities given up or reduced– continued use despite problems

Page 12: Back to basics! Substance abuse/drug addiction/withdrawal March 19, 2012 Dr. Gabrielle Cyr PGY-3 resident, psychiatry University of Ottawa

Standard drinks…

Page 13: Back to basics! Substance abuse/drug addiction/withdrawal March 19, 2012 Dr. Gabrielle Cyr PGY-3 resident, psychiatry University of Ottawa

Canada’s low risk alcohol drinking guidelines

• No more than:

– Women ≤ 10 drinks/week (≤ 2 drinks/day most days)

– Men ≤ 15 drinks/week (≤ 3 drinks/day most days)

– In one sitting:• Women, no more than 3 drinks• Men, no more than 4 drinks

– Plan a few non drinking days/week

CCSA, Canada's Low-Risk Alcohol Drinking Guidelines, November 2011

Page 14: Back to basics! Substance abuse/drug addiction/withdrawal March 19, 2012 Dr. Gabrielle Cyr PGY-3 resident, psychiatry University of Ottawa

Alcohol - assessment

• Always screen;– CAGE questionnaire

• Have you ever felt the need to CUT down on your drinking?

• Ever felt ANNOYED by criticism of your drinking?• Ever felt GUILTY about your drinking?• Ever had a drink first thing in the morning? (EYE

OPENER)

– Score 0 or 1 (≥ 2 = significant)– Quick / sensitive 75-85%

Page 15: Back to basics! Substance abuse/drug addiction/withdrawal March 19, 2012 Dr. Gabrielle Cyr PGY-3 resident, psychiatry University of Ottawa

Alcohol - assessment

• Investigations– LFT’s (GGT, AST:ALT ratio 2:1)– CBC (↑MCV, anemia, thrombocytopenia) – For baseline and monitoring

• Potential complications– Cardiac (HTN, cardiomyopathy)– GI (GI tract cancers, gastritis, bleeds)– Neuro (Wernicke-Korsakoff)

Page 16: Back to basics! Substance abuse/drug addiction/withdrawal March 19, 2012 Dr. Gabrielle Cyr PGY-3 resident, psychiatry University of Ottawa

Potentially deadly withdrawals…

• Alcohol

• Benzodiazepines/Barbiturates

• GHB…

Page 17: Back to basics! Substance abuse/drug addiction/withdrawal March 19, 2012 Dr. Gabrielle Cyr PGY-3 resident, psychiatry University of Ottawa

Alcohol/Benzodiazepine withdrawal

– Autonomic hyperactivity (e.g. sweating or pulse rate greater than 100), also labile BP

– Increased hand tremor– Insomnia– Nausea or vomiting– Transient visual, tactile, or auditory hallucinations or

illusions– Psychomotor agitation– Anxiety– Grand mal seizures

• Withdrawal seizures: 6-48 hrs• DT’s: up to 24-72 hrs

Page 18: Back to basics! Substance abuse/drug addiction/withdrawal March 19, 2012 Dr. Gabrielle Cyr PGY-3 resident, psychiatry University of Ottawa

Stages of change

Page 19: Back to basics! Substance abuse/drug addiction/withdrawal March 19, 2012 Dr. Gabrielle Cyr PGY-3 resident, psychiatry University of Ottawa

Alcohol/benzo withdrawal management

• Have to follow motivation for change– Stages of change– Motivationnal interviewing

• Outpatient management:– Mild-moderate problem (set drinking goals)– No history of severe withdrawal– Good support/regular follow-up– AA

Page 20: Back to basics! Substance abuse/drug addiction/withdrawal March 19, 2012 Dr. Gabrielle Cyr PGY-3 resident, psychiatry University of Ottawa

Community outpatient treatment (Ottawa)

• The Royal Substance Use and Concurrent Disorders Program

• Sandy Hill Addictions and Mental Health• Rideauwood Addiction and Family Services• Amethyst Women’s Centre• Serenity Renewal for Families• LESA (Lifestyle Enrichment for Senior Adults)• CMHA

Page 21: Back to basics! Substance abuse/drug addiction/withdrawal March 19, 2012 Dr. Gabrielle Cyr PGY-3 resident, psychiatry University of Ottawa

Alcohol/benzo withdrawal management

• Non medical detoxification/residential treatment– Patient intoxicated/mild withdrawal– Can take own medication– Medically stable– Short stay only

Page 22: Back to basics! Substance abuse/drug addiction/withdrawal March 19, 2012 Dr. Gabrielle Cyr PGY-3 resident, psychiatry University of Ottawa

Residential treatment (Ottawa)

• Empathy House

• Serenity House

• Sobriety House

• VESTA

• Maison Fraternité

• The ROMHC Meadow Creek

Page 23: Back to basics! Substance abuse/drug addiction/withdrawal March 19, 2012 Dr. Gabrielle Cyr PGY-3 resident, psychiatry University of Ottawa

Alcohol/benzo withdrawal management

• Medically supervised detoxification (inpatient)– Severe alcohol/benzodiazepine withdrawal

• Delirium tremens• Alcohol withdrawal seizures• Past history/current

– Polysubstance use and medical comorbidities (severe CAD, etc.), high dose benzos

– Pregnancy

Page 24: Back to basics! Substance abuse/drug addiction/withdrawal March 19, 2012 Dr. Gabrielle Cyr PGY-3 resident, psychiatry University of Ottawa

Alcohol/benzo withdrawal management

• Inpatient treatment/medical detox– Front loading

• High doses, early in withdrawal state• Diazepam 10-20mg q 1-2h for CIWA ≥10, goal is

CIWA ≤ 8/sedation• Useful in ER

– Fixed dosing• Diazepam/Lorazepam QID with PRN doses q2-4h• Useful if past history DT’s/seizures

Page 25: Back to basics! Substance abuse/drug addiction/withdrawal March 19, 2012 Dr. Gabrielle Cyr PGY-3 resident, psychiatry University of Ottawa

Alcohol/benzo withdrawal management

• Be careful!– For ALL patients

• Thiamine 100mg IM for 3 days, then PO (up to 2 months)

– Lorazepam safer if hepatic function unknown

Page 26: Back to basics! Substance abuse/drug addiction/withdrawal March 19, 2012 Dr. Gabrielle Cyr PGY-3 resident, psychiatry University of Ottawa

Alcohol addiction treatment

• Disulfiram (Antabuse)– Blockade of Aldehyde dehydrogenase

• Flushing/nausea+vomiting/hypotension on ingestion of alcohol

– Aversive agent– Mild LFT elevation, risk of fatal hepatotoxicity

(rare)

Page 27: Back to basics! Substance abuse/drug addiction/withdrawal March 19, 2012 Dr. Gabrielle Cyr PGY-3 resident, psychiatry University of Ottawa

Alcohol addiction treatment

• Naltrexone– Opioid antagonist– May reduce cravings for alcohol– SE: nausea+vomiting, headaches, fatigue– Contra-indications: Increased LFT’s, pregnant

+breastfeeding, opioid dependence

Page 28: Back to basics! Substance abuse/drug addiction/withdrawal March 19, 2012 Dr. Gabrielle Cyr PGY-3 resident, psychiatry University of Ottawa

Opiate withdrawal

• Nausea/vomiting, diarrhea, sweating, lacrimation• Piloerection• Pupillary dilatation• Myalgias• Dysphoric mood, insomnia, anxiety

• Not life threatening, but uncomfortable

Page 29: Back to basics! Substance abuse/drug addiction/withdrawal March 19, 2012 Dr. Gabrielle Cyr PGY-3 resident, psychiatry University of Ottawa

Opiate cessation

• Stopping «cold turckey»– Supportive measures,Clonidine as adjunct

• Tapering schedule with long-acting opiate– Equivalence; decrease by 10%/week

• Maintenance treatment– Methadone (full agonist)– Buprnorphine/Naloxone (Suboxone) (partial agonist)

Page 30: Back to basics! Substance abuse/drug addiction/withdrawal March 19, 2012 Dr. Gabrielle Cyr PGY-3 resident, psychiatry University of Ottawa

Methadone replacement

• Synthetic opioid

• Useful if high dose opiate abusers, addicted for a long time, relapses, etc.

• MD’s need a special license to order

• Usually daily pick-up at pharmacy

Page 31: Back to basics! Substance abuse/drug addiction/withdrawal March 19, 2012 Dr. Gabrielle Cyr PGY-3 resident, psychiatry University of Ottawa

Safe prescribing – controlled substances

• Under Canada’s Controlled Drugs and Substances Act– Narcotics and other drugs of potential for abuse

(methylphenidate, benzodiazepines and barbiturates)

– Need to correctly identify patient– Information can be collected by Narcotics Safety

and Awareness Act (NSAA)– Should never write repeats on narcotic prescription

Page 32: Back to basics! Substance abuse/drug addiction/withdrawal March 19, 2012 Dr. Gabrielle Cyr PGY-3 resident, psychiatry University of Ottawa

Nicotine…

• Counselling, advice

• Nicotine replacement therapy– Patch, gum, inhaler, lozenges– Usually treat for up to 2-3 months

• Bupropion (Zyban)– Usually 2 months of treatment, up to 1 year – Contraindicated in Seizure disorder

Page 33: Back to basics! Substance abuse/drug addiction/withdrawal March 19, 2012 Dr. Gabrielle Cyr PGY-3 resident, psychiatry University of Ottawa

Nicotine…

• Varenicline (Champix)– Some studies have showmn exacerbation of

pre-existing psychiatric conditions – so monitor

– Usually treat for 3 months

Page 34: Back to basics! Substance abuse/drug addiction/withdrawal March 19, 2012 Dr. Gabrielle Cyr PGY-3 resident, psychiatry University of Ottawa

Prevention/harm reduction strategies

• Safer environment to use substances– Supervised injection sites

• Safer use of substances– Crack pipe programs, needle exchange programs

• Alternative safe substances– Methadone Maintenance

• Modification/Management of related risk behaviours– HIV/STD screening– Safe sex education– Condoms

Page 35: Back to basics! Substance abuse/drug addiction/withdrawal March 19, 2012 Dr. Gabrielle Cyr PGY-3 resident, psychiatry University of Ottawa

References

• Dr Willow’s presentation, substance use

• DSM-IV

• Toronto Notes

• Up to date

• Narcotics Safety and Awareness Act

• Canada’s low risk alcohol drinking guidelines